Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice

ObjectiveThe purpose of this study was to determine the effect of quercetin on the antitumor activity of cisplatin and its side-effects.MethodsEMT6 cells, a mouse breast cancer cell line, were injected subcutaneously in mice to generate a breast tumor-bearing mouse model. Experimental groups were di...

Full description

Bibliographic Details
Main Authors: Hyunju Liu, Jung In Lee, Tae-Gyu Ahn
Format: Article
Language:English
Published: Korean Society of Obstetrics and Gynecology 2019-07-01
Series:Obstetrics & Gynecology Science
Subjects:
Online Access:http://ogscience.org/upload/pdf/ogs-62-242.pdf
_version_ 1818419443039993856
author Hyunju Liu
Jung In Lee
Tae-Gyu Ahn
author_facet Hyunju Liu
Jung In Lee
Tae-Gyu Ahn
author_sort Hyunju Liu
collection DOAJ
description ObjectiveThe purpose of this study was to determine the effect of quercetin on the antitumor activity of cisplatin and its side-effects.MethodsEMT6 cells, a mouse breast cancer cell line, were injected subcutaneously in mice to generate a breast tumor-bearing mouse model. Experimental groups were divided into four groups: control (C), quercetin (Q), cisplatin (CP), and cisplatin+quercetin (CP+Q).ResultsThe tumor volume of the CP+Q group was significantly lower than that of the CP group. Serum blood urea nitrogen and creatinine levels in the CP+Q group were lower than those in the CP group. Renal γ-glutamyltranspeptidase and alkaline phosphatase activities were significantly higher in the CP+Q group than in the CP group, and the content of renal thiobarbituric acid reactive substance was significantly lower in the CP+Q group than that in the CP group. These results suggested that quercetin and cisplatin synergistically increased cellular toxicity in breast cancer cells and mediated cancer growth inhibition, thereby enhancing the antitumor effect of cisplatin compared to when only cisplatin was administered. Quercetin also reduced renal toxicity, which arose as a potential a side effect of cisplatin.ConclusionThe enhanced antitumor effect of cisplatin and decreased renal toxicity after quercetin treatment suggested the applicability of quercetin as an adjuvant for chemotherapeutic agents.
first_indexed 2024-12-14T12:38:39Z
format Article
id doaj.art-41637d72552844b3bc34cec8c491d6dc
institution Directory Open Access Journal
issn 2287-8572
2287-8580
language English
last_indexed 2024-12-14T12:38:39Z
publishDate 2019-07-01
publisher Korean Society of Obstetrics and Gynecology
record_format Article
series Obstetrics & Gynecology Science
spelling doaj.art-41637d72552844b3bc34cec8c491d6dc2022-12-21T23:00:58ZengKorean Society of Obstetrics and GynecologyObstetrics & Gynecology Science2287-85722287-85802019-07-0162424224810.5468/ogs.2019.62.4.242580Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing miceHyunju Liu0Jung In Lee1Tae-Gyu Ahn2Department of Obstetrics and Gynecology, College of Medicine, Chosun University, Gwangju, .KoreaDepartment of Internal Medicine, College of Medicine, Chosun University, Gwangju, .KoreaDepartment of Obstetrics and Gynecology, College of Medicine, Chosun University, Gwangju, .KoreaObjectiveThe purpose of this study was to determine the effect of quercetin on the antitumor activity of cisplatin and its side-effects.MethodsEMT6 cells, a mouse breast cancer cell line, were injected subcutaneously in mice to generate a breast tumor-bearing mouse model. Experimental groups were divided into four groups: control (C), quercetin (Q), cisplatin (CP), and cisplatin+quercetin (CP+Q).ResultsThe tumor volume of the CP+Q group was significantly lower than that of the CP group. Serum blood urea nitrogen and creatinine levels in the CP+Q group were lower than those in the CP group. Renal γ-glutamyltranspeptidase and alkaline phosphatase activities were significantly higher in the CP+Q group than in the CP group, and the content of renal thiobarbituric acid reactive substance was significantly lower in the CP+Q group than that in the CP group. These results suggested that quercetin and cisplatin synergistically increased cellular toxicity in breast cancer cells and mediated cancer growth inhibition, thereby enhancing the antitumor effect of cisplatin compared to when only cisplatin was administered. Quercetin also reduced renal toxicity, which arose as a potential a side effect of cisplatin.ConclusionThe enhanced antitumor effect of cisplatin and decreased renal toxicity after quercetin treatment suggested the applicability of quercetin as an adjuvant for chemotherapeutic agents.http://ogscience.org/upload/pdf/ogs-62-242.pdfquercetincisplatinbreast cancerrenal injury
spellingShingle Hyunju Liu
Jung In Lee
Tae-Gyu Ahn
Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice
Obstetrics & Gynecology Science
quercetin
cisplatin
breast cancer
renal injury
title Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice
title_full Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice
title_fullStr Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice
title_full_unstemmed Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice
title_short Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice
title_sort effect of quercetin on the anti tumor activity of cisplatin in emt6 breast tumor bearing mice
topic quercetin
cisplatin
breast cancer
renal injury
url http://ogscience.org/upload/pdf/ogs-62-242.pdf
work_keys_str_mv AT hyunjuliu effectofquercetinontheantitumoractivityofcisplatininemt6breasttumorbearingmice
AT junginlee effectofquercetinontheantitumoractivityofcisplatininemt6breasttumorbearingmice
AT taegyuahn effectofquercetinontheantitumoractivityofcisplatininemt6breasttumorbearingmice